The homologous R823 residue in DNMT3A (i.e., R882) is a hotspot mutational site in AML, with the R882H mutation representing the most frequent AML‐linked mutation among patients (Ley et al., 2010). Here, DNMT3A is linked to acute myeloid leukemia.